Naproxen Orion

Naproxen, the active ingredient in Naproxen Orion, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve mild to moderate pain, reduce inflammation, and lower fever in adults.\n\nGNH India supplies Naproxen Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes.\n\n- Mild to moderate pain: provides analgesic relief for headaches, dental pain, and musculoskeletal discomfort.\n- Osteoarthritis: helps decrease joint pain and improve functional mobility.\n- Rheumatoid arthritis: reduces inflammatory joint swelling and pain.\n- Fever: lowers elevated body temperature associated with acute infections or inflammatory conditions.

Naproxen may cause a range of adverse reactions, from mild to serious.\n\nCommon Side Effects:\n- Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort.\n- Headache: mild to moderate intensity.\n- Dizziness or vertigo.\n- Skin rash or pruritus.\n\nSerious or Rare Side Effects:\n- Gastrointestinal bleeding or ulceration.\n- Renal impairment or reduced kidney function.\n- Hepatic dysfunction, including elevated liver enzymes.\n- Severe skin reactions such as Stevens‑Johnson syndrome or anaphylaxis.

Before prescribing or dispensing Naproxen Orion, consider the following safety measures.\n\n- Assess gastrointestinal risk: evaluate history of ulcers, bleeding, or chronic NSAID use.\n- Evaluate cardiovascular status: avoid in patients with uncontrolled hypertension or recent thrombotic events.\n- Monitor renal function: use caution in patients with existing kidney disease or dehydration.\n- Review concomitant medications: check for other NSAIDs, anticoagulants, or corticosteroids.\n- Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture and direct sunlight.

Naproxen can interact with several drug classes, altering efficacy or safety.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): increased risk of serious bleeding.\n- Other NSAIDs or aspirin: additive gastrointestinal toxicity.\n- Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.\n\nModerate Interactions (Monitor Closely):\n- Lithium: naproxen may raise lithium serum levels.\n- Methotrexate: reduced clearance leading to toxicity.\n- ACE inhibitors or diuretics: possible reduction in renal function, especially in volume‑depleted patients.